Biotest Pharmaceuticals researches and manufactures biotherapeutic products with a specialization in immunology and hematology. Biotest Pharmaceuticals is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyperimmune (IG) products which are antibody specific to high titer for treatment of modality.
Established in 2007, Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. Biotest Pharmaceuticals employs more than 1,075 employees in the US. Biotest Pharmaceuticals is a subsidiary of Biotest AG, a German-based global provider of plasma protein therapies that employs approximately 1,800 people worldwide
